Today: 21 May 2026
AppLovin stock price: What to watch after the short-seller report as shares steady into next week
25 January 2026
1 min read

AppLovin stock price: What to watch after the short-seller report as shares steady into next week

New York, Jan 24, 2026, 18:01 EST — The market has closed.

  • Shares closed Friday roughly 0.5% higher following a volatile week
  • A short-seller report sparked scrutiny, with the company quickly firing back to defend its governance and compliance.
  • Traders are focused on any further disclosures ahead of the February 11 earnings report

AppLovin Corp shares ended Friday 0.5% higher at $524.41, after trading between $509.36 and $535.68 during the session. U.S. markets were then closed for the weekend.

The stock has swung wildly since mid-month, dropping roughly 22% from its close on Jan. 13 following several sharp daily swings this week. That volatility will be key heading into Monday’s open as investors weigh headline risk alongside the company’s growth narrative.

Late Thursday, Pomerantz LLP announced it is probing claims for AppLovin investors, citing the recent selloff linked to allegations in a research report. The firm framed its notice as an investigation into possible securities fraud or other illegal business practices.

The selloff began after CapitalWatch, a short seller betting against the stock, claimed AppLovin’s business and shareholder network were tied to a global money-laundering scheme. These allegations remain unproven.

AppLovin fired back, labeling the allegations “patently false” and saying it “categorically reject[s] the claims made in this report,” according to an emailed statement cited by Investing.com. The company added that if the report’s premise were true, it would point to a wider breakdown across the mobile advertising and app-store ecosystem. Investing.com

AppLovin provides software aimed at helping app developers and other companies market, monetize, and expand their audiences. It’s a key player in ad tech, attracting close attention. Comparable firms in the wider digital ad space include The Trade Desk and Unity Software, where investor sentiment can shift abruptly over concerns about data access, ad effectiveness, or platform ties.

The risks extend beyond legal troubles. More short reports, fresh lawsuits, or tighter regulatory scrutiny could cap the stock’s upside, turning guidance into the headline over quarterly beats or misses.

Regulatory scrutiny isn’t new for AppLovin. Reuters noted in October that the U.S. Securities and Exchange Commission had opened an investigation into the company’s data-collection methods, referencing a Bloomberg News story.

AppLovin plans to release its fourth-quarter and full-year 2025 earnings on Feb. 11 after U.S. markets close. CEO Adam Foroughi and CFO Matthew Stumpf will host a webcast at 5 p.m. ET to discuss the results.

Stock Market Today

  • Stock Market Today: Key Insights for May 21 Trading
    May 20, 2026, 10:27 PM EDT. Stocks in the news and major brokerage calls shape market sentiment as traders prepare for May 21. This report provides a complete trade setup, highlighting critical market movements and strategies. Stay informed with the essential data before entering trades today.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Goldman Sachs stock slides into Fed week after CEO pay disclosure
Previous Story

Goldman Sachs stock slides into Fed week after CEO pay disclosure

Vallourec’s Delphy hydrogen storage lands Hyvolution award nod as Paris show nears
Next Story

Vallourec’s Delphy hydrogen storage lands Hyvolution award nod as Paris show nears

Go toTop